Li W - Search Results

1

GABAergic signaling as a potential therapeutic target in cancers.

Yang Y, Ren L, Li W, Zhang Y, Zhang S, Ge B, Yang H, Du G, Tang B, Wang H, Wang J. Yang Y, et al. Among authors: li w. Biomed Pharmacother. 2023 May;161:114410. doi: 10.1016/j.biopha.2023.114410. Epub 2023 Feb 21. Biomed Pharmacother. 2023. PMID: 36812710 Free article. Review.

2

Graphene-clad microfibre saturable absorber for ultrafast fibre lasers.

Liu XM, Yang HR, Cui YD, Chen GW, Yang Y, Wu XQ, Yao XK, Han DD, Han XX, Zeng C, Guo J, Li WL, Cheng G, Tong LM. Liu XM, et al. Among authors: li wl. Sci Rep. 2016 May 16;6:26024. doi: 10.1038/srep26024. Sci Rep. 2016. PMID: 27181419 Free PMC article.

3

Members of FOX family could be drug targets of cancers.

Wang J, Li W, Zhao Y, Kang D, Fu W, Zheng X, Pang X, Du G. Wang J, et al. Among authors: li w. Pharmacol Ther. 2018 Jan;181:183-196. doi: 10.1016/j.pharmthera.2017.08.003. Epub 2017 Aug 19. Pharmacol Ther. 2018. PMID: 28830838 Review.

4

Research progress on the forkhead box C1.

Wang J, Li W, Zheng X, Pang X, Du G. Wang J, et al. Among authors: li w. Oncotarget. 2017 Nov 20;9(15):12471-12478. doi: 10.18632/oncotarget.22527. eCollection 2018 Feb 23. Oncotarget. 2017. PMID: 29552326 Free PMC article. Review.

5

miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway.

Li W, Yi J, Zheng X, Liu S, Fu W, Ren L, Li L, Hoon DSB, Wang J, Du G. Li W, et al. Among authors: li l. Clin Epigenetics. 2018 May 16;10:64. doi: 10.1186/s13148-018-0495-y. eCollection 2018. Clin Epigenetics. 2018. PMID: 29796115 Free PMC article.

6

3-O-acetyl-11-keto-β-boswellic acid exerts anti-tumor effects in glioblastoma by arresting cell cycle at G2/M phase.

Li W, Liu J, Fu W, Zheng X, Ren L, Liu S, Wang J, Ji T, Du G. Li W, et al. J Exp Clin Cancer Res. 2018 Jul 3;37(1):132. doi: 10.1186/s13046-018-0805-4. J Exp Clin Cancer Res. 2018. PMID: 29970196 Free PMC article.

7

The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy.

Zheng X, Li W, Ren L, Liu J, Pang X, Chen X, Kang D, Wang J, Du G. Zheng X, et al. Among authors: li w. Pharmacol Ther. 2019 Mar;195:85-99. doi: 10.1016/j.pharmthera.2018.10.011. Epub 2018 Oct 19. Pharmacol Ther. 2019. PMID: 30347210 Review.

8

Xiao-Xu-Ming decoction extract regulates differentially expressed proteins in the hippocampus after chronic cerebral hypoperfusion.

Wang YH, Yang YL, Cheng X, Zhang J, Li W, Du GH. Wang YH, et al. Among authors: li w. Neural Regen Res. 2019 Mar;14(3):470-479. doi: 10.4103/1673-5374.245471. Neural Regen Res. 2019. PMID: 30539815 Free PMC article.

9

Network pharmacology study of traditional Chinese medicines for stroke treatment and effective constituents screening.

Ren L, Zheng X, Liu J, Li W, Fu W, Tang Q, Wang J, Du G. Ren L, et al. Among authors: li w. J Ethnopharmacol. 2019 Oct 5;242:112044. doi: 10.1016/j.jep.2019.112044. Epub 2019 Jun 27. J Ethnopharmacol. 2019. PMID: 31255722

10

Competing Endogenous RNA and Coexpression Network Analysis for Identification of Potential Biomarkers and Therapeutics in association with Metastasis Risk and Progression of Prostate Cancer.

Pang X, Zhao Y, Wang J, Li W, Xiang Q, Zhang Z, Wu S, Liu A, Du G, Cui Y. Pang X, et al. Among authors: li w. Oxid Med Cell Longev. 2019 Aug 5;2019:8265958. doi: 10.1155/2019/8265958. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31467637 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

75,405 results

Search Page